AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.
AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AZ Health Connections
Celebrating 10 Years of Exenatide: The First GLP-1 RA Treatment Option
27 August 2015 20:03 BST
In 2005, a new medication was approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes by the U.S. Food and Drug Administration (FDA). Headlines over the following few days highlighted its unique origin.